CROWN
Natural health product licensed in Canada
- Licence holder
- Pranic Forest Artisan Apothecary Corp.
- NPN or DIN-HM
- 80081603
- Status
- Active licence
- Licence date
- 30 November 2017
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Mentha x piperita Source : Feuille | 2 Pour cent |
| Mentha x piperita Source : Herb flowering | 2 Pour cent |
| Matricaria chamomilla Source : Sommité | 0.5 Pour cent |
| Matricaria chamomilla Source : Fleur | 0.5 Pour cent |
| Salvia sclarea Source : Feuille | 0.5 Pour cent |
| Salvia sclarea Source : Sommité en fleurs (herbe) | 0.5 Pour cent |
| Aniba rosaeodora Source : Bois | 0.5 Pour cent |
| Lavandula angustifolia Source : Sommité en fleurs (herbe) | 1 Pour cent |
| Origanum majorana Source : Sommité en fleurs (herbe) | 0.5 Pour cent |
| Origanum majorana Source : Feuille | 0.5 Pour cent |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Huile | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in aromatherapy to help relieve headache. Used in aromatherapy as a nervine/ calmative.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Précautions et mises en garde
Keep out of the reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If you have epilepsy or asthma, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner. Avoid exposure of applied area(s) to the sun. Do not expose the applied area(s) to the sun for 24 to 48 hours after application. Not for oral use.
Source
Official Health Canada record, licence 80081603
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.